COVID-19 Vaccine Tickers $NVAX, $MRK, $PFE, $JNJ, $INO, and $MRNA Surge +7.7% in Weekly Performance

Robots for this industry :
Choppy Market Trader for Beginners: Medical Stocks (TA&FA)
Swing Trader for Beginners: Trading in Markets Trending Down (TA&FA)

In a remarkable turn of events, Covid-19 vaccine companies have shown a robust performance, boasting a significant increase of 7.7% in the past week. This surge is driven by a selection of key players in the field, including NVAX, MRK, PFE, JNJ, INO, and MRNA. These stocks are currently exhibiting a positive outlook, supported by a comprehensive analysis of 15 indicators, with the Tickeron Fear & Greed Index reflecting an optimistic sentiment. Furthermore, Tickeron's predictive analytics suggest a potential increase of more than 4.00% within the next month, with a likelihood of 63%. Over the past month, the daily ratio of advancing to declining volumes stood at 1 to 1.59, indicating a balanced and stable market.

Market Cap Overview

The Covid-19 vaccine theme is associated with an average market capitalization of approximately $145.4 billion. This reflects the diverse range of market caps within this theme, with values spanning from $135.7 million to $376.1 billion. Johnson & Johnson (JNJ) leads the pack in terms of valuation, with a substantial market cap of $376.1 billion, while Inovio Pharmaceuticals (INO) is the lowest valued company in this group, with a market cap of $135.7 million. However, it's worth noting that the market cap of JNJ experienced significant fluctuations recently, dropping by $25.6 billion on August 26, 2023, and suffering a staggering $85.2 billion decrease just a few months prior.

Price Movements and Notable News

When considering the price movements across all stocks within the Covid-19 vaccine theme, there's a notable weekly price growth of 7.7%. However, the monthly average price growth stands at -0.01%, and the quarterly average is -20.08%. INO stands out as the top gainer, experiencing a remarkable price growth of 42.43%. On the flip side, MRNA encountered a substantial decline, with a -1.44% decrease.

Recent highlights include Inovio Pharmaceuticals (INO) as a top weekly gainer for penny stocks, achieving an impressive 33.49% rise. Meanwhile, Moderna (MRNA) demonstrated strength by gaining 5.23%, and Pfizer (PFE) faced headwinds, declining by 5.14%.

Volume Growth Insights

In terms of volume growth, the average weekly increase across all stocks in the Covid-19 vaccine theme is a substantial 25.99%. When looking at monthly trends, the average growth surges to 92.96%, and the quarterly growth is still notable at 57.23%. There are instances, such as those on 7/6/23 and 6/24/23, where the volume for Inovio Pharmaceuticals surged, achieving record-breaking daily growth of 256% and 278%, respectively, of the 65-Day Volume Moving Average.

Technical Analysis on Key Stocks

1. MRK - Stochastic Oscillator Ascends Out of Oversold Territory On October 6, 2023, the Stochastic Indicator for MRK moved out of oversold territory, signaling a potential bullish trend. Historical data analyzed by Tickeron's A.I.dvisor reveals that in 76% of similar instances, the stock moved higher in the following days. The current price of $103.45 is within the range of $101.93 support and $115.46 resistance, showing a positive uptrend during the week of 10/03/23 - 10/10/23.

2. PFE - RSI Indicator Indicates an Uptrend The RSI Indicator for PFE emerged from oversold territory on September 29, 2023, hinting at a potential shift from a downward trend to an upward one. In 71% of comparable cases, stocks moved higher after such an occurrence. The current price of $33.10 is within the range of $30.56 support and $40.90 resistance, although it faced a slight decline during the week of 10/03/23 - 10/10/23.

3. JNJ - RSI Oscillator Shows Signs of Uptrend On October 5, 2023, the RSI Indicator for JNJ left oversold territory, suggesting a possible transition from a downward trend to an upward one. Historical data indicates that in 56% of similar cases, the stock moved higher. The current price of $156.18 is trading between $150.88 support and $160.27 resistance, showcasing a recent uptrend during the week of 10/03/23 - 10/10/23.

In summary, the Covid-19 vaccine companies are experiencing a positive upswing in the market, with stocks in this theme demonstrating notable performance, bolstered by a series of key technical indicators. Investors should remain vigilant and consider these analyses while making informed decisions in this dynamic market environment.